Executive TL;DR:

• CRISPR technology shows promise in selectively targeting and destroying cancer cells.
• Researchers face challenges in delivering the CRISPR enzyme to targeted cells efficiently.
• Potential treatments are still in the experimental phase, with years to decades before human trials.

The Buzz Score

The Internet’s Verdict: 70% Hyped, 30% Skeptical

Expert Opinions

Some experts express caution about the hype surrounding CRISPR technology. As one expert notes:

CRISPR is an extremely overhyped approach which found a marketing engine via popular science.

Others are more optimistic, recalling past experiences with proposed cancer cures:

I hope this finally works out. I remember almost exactly ten years ago I got excited about one of these proposed cancer cures, tried to talk about it at lunch with my coworkers, and they laughed at me for believing.

Challenges Ahead

Delivery remains a critical challenge for CRISPR therapies, with one expert pointing out that

Much like other CRISPR therapies, delivery is a critical challenge, i.e., getting the large genome-cutting enzyme to all the targeted cells efficiently.

Focus Keyword: CRISPR Cancer